NAMs and the Next Inflection Point for Imaging Manufacturers
By Dameka Williams, Chief Research & Insights Officer, Science and Medicine Group For decades, diagnostic imaging manufacturers have anchored their growth strategies to clinical demand, capital cycles, and incremental modality innovation. However, a quieter (and potentially more disruptive) shift is now underway upstream in the life sciences. While often discussed in the context of toxicology […]
